Ranger Investment Management, L.P. Abb Vie Inc. Transaction History

Ranger Investment Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1,227 - $1,351	12 Added 46.15%	38 $4,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $885 - $1,195	-11 Reduced 29.73%	26 $3,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $293 - $392	-4 Reduced 9.76%	37 $4,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1,322 - $1,590	-21 Reduced 33.87%	41 $3,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $308 - $363	4 Added 6.9%	62 $5,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $4,051 - $5,174	58	58 $5,000

3,785

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ranger Investment Management, L.P. with notifications on news.